Jianwen Wu, MD
Internal Medicine · Chandler, AZNPI 1154381218
Payments from drug & device makers
Across 158 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$379
- Novo Nordisk$374
- AstraZeneca$324
- Boehringer Ingelheim$252
- Lilly USA, LLC$224
- Pfizer$204
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,75999%
- Education$191%
- Gifts$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 24 | $379 |
| Novo Nordisk | 24 | $374 |
| AstraZeneca | 18 | $324 |
| Boehringer Ingelheim | 12 | $252 |
| Lilly USA, LLC | 13 | $224 |
| Pfizer | 10 | $204 |
| AbbVie(2 entities) | 9 | $140 |
| Sanofi Pasteur Inc. | 5 | $108 |
| Merck | 4 | $91 |
| GSK | 5 | $77 |
| Amarin Pharma, Inc. | 4 | $71 |
| Abbott | 2 | $50 |
| Bayer | 3 | $44 |
| Almatica Pharma LLC | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Dexcom, Inc. | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $30 |
| Medtronic | 1 | $28 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Exact Sciences | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Globus Medical | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Renalytix AI, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Novartis | 1 | $13 |
| Circassia Inc. | 1 | $13 |
How this compares
$2,796 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 87 | $102,541 |
| JardianceEmpagliflozin | 50 | $69,127 |
| JanuviaSitagliptin Phosphate | 52 | $59,940 |
| EliquisApixaban | 43 | $51,021 |
| ProliaDenosumab | 25 | $43,912 |
| MounjaroTirzepatide | 38 | $43,130 |
| OzempicSemaglutide | 25 | $33,931 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $20,579 |
| XareltoRivaroxaban | 13 | $16,413 |
| VascepaIcosapent Ethyl | 21 | $14,057 |
| TradjentaLinagliptin | 16 | $13,128 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $9,527 |
| Praluent PenAlirocumab | 12 | $6,266 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $5,924 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $5,870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $324 | $128,990135 claims |
| Boehringer IngelheimJardiance, Tradjenta | $252 | $82,25566 claims |
| MerckJanuvia | $91 | $59,94052 claims |
| PfizerEliquis | $204 | $51,02143 claims |
| AmgenProlia | $379 | $43,91225 claims |
| Lilly USA, LLCMounjaro | $224 | $43,13038 claims |
| Novo NordiskOzempic | $374 | $33,93125 claims |
| Johnson & JohnsonXarelto | $30 | $16,41313 claims |
| GSKBreo Ellipta | $77 | $9,52718 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $15 | $4,68712 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $35 | $1,596241 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Chandler
- Janelle WeyerChandler$5.5M
- Randall SeveranceChandler$3.1M
- Punal PatelChandler$604K
- Yessica SachdevaMesa$13.7M
- Louise TaberPhoenix$8.5M
- Robert MutterperlTucson$5.3M
- Jalal AbbasSun City West$4.8M
- Nebojsa SkrepnikTucson$4.7M
- Philip MathewTempe$4.1M
- Justin MoserScottsdale$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.